GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Activity
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

103 hedge funds and large institutions have $287M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
+6
Holders Change %
+6.19%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
42
Reduced
18
Closed
18
Calls
$1.42M
Puts
$676K
Net Calls
+$746K
Net Calls Change
+$444K

Top Buyers

1
State Street
1
State Street
Massachusetts
$20.2M
2
PBA
2
Paradigm Biocapital Advisors
New York
$11M
3
Fisher Asset Management
3
Fisher Asset Management
Washington
$36.7M
4
Millennium Management
4
Millennium Management
New York
$14.6M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$4.32M

Top Sellers

1
WP
1
Woodline Partners
California
$3.46M
2
CA
2
CHI Advisors
New York
$4.05M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.28M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$1.28M
5
Citadel Advisors
5
Citadel Advisors
Florida
$1.26M
Name Holding Trade Value Shares
Change 		Shares
Change %
Fisher Asset Management
1
Fisher Asset Management
Washington
$36.7M +$7.83M +626,777 +27%
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$25.5M -$1.07M -85,676 -4%
Vanguard Group
3
Vanguard Group
Pennsylvania
$21.1M +$824K +65,952 +4%
State Street
4
State Street
Massachusetts
$20.2M +$18.4M +1,476,175 +1,038%
BlackRock
5
BlackRock
New York
$19M +$1.88M +150,376 +11%
Millennium Management
6
Millennium Management
New York
$14.6M +$5.55M +444,376 +61%
PBA
7
Paradigm Biocapital Advisors
New York
$11M +$11M +884,574 New
MB
8
MPM BioImpact
Massachusetts
$10.7M – – –
Marshall Wace
9
Marshall Wace
United Kingdom
$7.9M +$1.94M +155,356 +33%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$6.24M +$138K +11,021 +2%
RJA
11
Raymond James & Associates
Florida
$5.99M +$518K +41,479 +9%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$5.83M -$894K -71,557 -13%
CSS
13
Cubist Systematic Strategies
Connecticut
$5.56M +$2.33M +186,929 +72%
TCM
14
Tekla Capital Management
Massachusetts
$5.29M – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.34M +$66.9K +5,360 +2%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$4.32M +$4.32M +346,000 New
Morgan Stanley
17
Morgan Stanley
New York
$4.23M +$1.94M +155,643 +85%
Bank of America
18
Bank of America
North Carolina
$4.2M +$1.01M +80,901 +32%
Goldman Sachs
19
Goldman Sachs
New York
$4.14M -$102K -8,204 -2%
Voloridge Investment Management
20
Voloridge Investment Management
Florida
$4.11M +$4.11M +328,800 New
CA
21
CHI Advisors
New York
$4.05M -$5.54M -443,290 -58%
RPAM
22
Rhenman & Partners Asset Management
Sweden
$3.94M +$574K +53,863 +17%
WP
23
Woodline Partners
California
$3.46M -$19M -1,520,282 -85%
Two Sigma Investments
24
Two Sigma Investments
New York
$3.28M +$1.88M +150,250 +134%
Norges Bank
25
Norges Bank
Norway
$2.82M +$2.82M +225,700 New
1
2 3 4 5